Berthiaume Institute for Precision Health · Technology Bridge Fund
We’re delighted to announce that the pdnano lab has received a Berthiaume Institute for Precision Health (BIPH) Technology Bridge Fund award. The Technology Bridge program supports promising precision-health projects in generating the additional preliminary data needed to strengthen high-impact grant resubmissions.
The funded project — Multispecific Bridge-Nanoparticle Loading and T-Cell Engagement for Refractory Ovarian Cancer — is led by PI Prakash D. Nallathamby (BIPH) in collaboration with Co-PI Sharon Stack (Harper Cancer Research Institute). It advances a nanoparticle platform designed to recruit a patient’s own immune cells against ovarian tumor cells, a strategy aimed at one of the most treatment-resistant cancers in women.
Building on proof-of-principle results from the lab’s broader oncology pipeline, the Bridge project will generate targeted preliminary datasets that directly address reviewer feedback from a prior CDMRP Ovarian Cancer Research Program submission. The work will position the team for a strengthened resubmission to the FY26 OCRP Pilot Award and a planned NIH R21.
We thank BIPH for its support and look forward to sharing our progress.
Recent Comments